Cartesian Therapeutics, Inc. — Director's Dealing 2020

Oct 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-10-23

Reporting Person: Kishimoto Takashi Kei (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-23	Common Stock	M	30000	$2.77	Acquired	126149	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-23	Employee Stock Option (right to buy)	$2.77	M	30000	Disposed	2021-09-07	Common Stock (30000.0)	Direct

Footnotes

F1: Includes 6,410 shares of common stock acquired on March 2, 2020 and 3,625 shares of common stock acquired on August 31, 2020, in each case under the issuer's 2016 Employee Stock Purchase Plan.

F2: The shares underlying the option are fully vested.